منابع مشابه
Viruses Associated with Acute Respiratory Infections SUZANNE
Since the discovery of the rhinoviruses and respiratory syncytial virus only a few surveys have been made on the incidence of infections by the different respiratory viruses in the general population and the frequency with which they cause respiratory disease (Hilleman et al., 1962 ; Conference on Newer Respiratory Disease Viruses, 1963 ; Higgins et al., 1963). The present report describes the ...
متن کاملSuzanne Eaton: The beautiful logic of development
D uring development, cells tune their gene expression and determine their position within a growing tissue by referencing the local concentration of certain secreted proteins called morphogens. Morphogens are often present in a concentration gradient across tissues, but, until fairly recently, it wasn't clear how such gradients are established or how morphogens reach their target cells. Suzanne...
متن کاملMore Than Lightning in a Bottle and Far From ReadyMade
The Pareto Principle, named after economist Vilfredo Pareto who developed the “80/20” rule in the late 1800s, specifies that 80% of the effects come from 20% of the causes. During the past century, researchers focused on business, product consumption, medicine, and the behavioral sciences have observed the same basic persistent pattern regarding the “vital few and trivial many” (Juran, 1954). N...
متن کاملSuzanne Pfeffer: Sorting through membrane trafficking
S uzanne Pfeffer always wanted to know what makes the human body tick. In many respects, we're still working on deciphering the fi rst page of the body's operating manual—which Pfeffer says is fi ne, since it means there's plenty of room for new discoveries. Pfeffer had her fi rst publication as an undergraduate at UC Berkeley (1), which got her hooked on the spirit of scientifi c inquiry. Foll...
متن کاملQ&A: Suzanne Topalian on immune therapies.
Suzanne Topalian, MD, professor of surgery and oncology and director of the melanoma program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD, discusses progress with drugs that inhibit immune-checkpoint receptors and ligands, including PD-1 and PD-L1 inhibitors.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Vol 22 (2020)
سال: 2020
ISSN: 2396-9008
DOI: 10.14324/111.2396-9008.052